TrialInternational journal of clinical oncology2015

Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naïve patients with advanced non-squamous non-small cell lung cancer.

Yuichi Takiguchi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.